|
GNAI3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.128000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.629800E-02 |
| Normal-vs-Stage2 |
2.292800E-01 |
| Normal-vs-Stage3 |
5.443200E-01 |
| Normal-vs-Stage4 |
9.217800E-01 |
| Stage1-vs-Stage2 |
9.343000E-01 |
| Stage1-vs-Stage3 |
6.590400E-01 |
| Stage1-vs-Stage4 |
4.113800E-01 |
| Stage2-vs-Stage3 |
7.542200E-01 |
| Stage2-vs-Stage4 |
5.061600E-01 |
| Stage3-vs-Stage4 |
7.694800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.505900E-02 |
| Normal-vs-AfricanAmerican |
1.652640E-01 |
| Normal-vs-Asian |
8.628600E-01 |
| Caucasian-vs-AfricanAmerican |
9.678600E-01 |
| Caucasian-vs-Asian |
7.538800E-01 |
| AfricanAmerican-vs-Asian |
7.444000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.279200E-03 |
| Normal-vs-Female |
2.723800E-01 |
| Male-vs-Female |
1.240270E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.002300E-02 |
| Normal-vs-Extreme_Weight |
1.284260E-02 |
| Normal-vs-Obese |
4.695600E-01 |
| Normal-vs-Extreme_Obese |
2.254400E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.399200E-01 |
| Normal_Weight-vs-Obese |
3.636000E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.530000E-01 |
| Extreme_Weight-vs-Obese |
1.537580E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.856200E-01 |
| Obese-vs-Extreme_Obese |
4.433800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.494200E-01 |
| Normal-vs-Age(41-60Yrs) |
4.211400E-01 |
| Normal-vs-Age(61-80Yrs) |
1.416360E-02 |
| Normal-vs-Age(81-100Yrs) |
1.109830E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.857200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.633010E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.375600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.680300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.030830E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.551000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.231620E-01 |
| Normal-VS-Type2 PRCC |
9.617000E-03 |
| Normal-VS-KIRP CIMP |
1.287160E-01 |
| Normal-VS-Unclassified PRCC |
3.635000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.096040E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.806100E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
8.955800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.724400E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.389600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.897500E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.259700E-03 |
| Normal-vs-N1 |
7.483600E-01 |
| Normal-vs-N2 |
5.244000E-01 |
| N0-vs-N1 |
8.673800E-02 |
| N0-vs-N2 |
4.348100E-02 |
| N1-vs-N2 |
5.887800E-01 |
|
|
